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Chitinases are ubiquitous chitin-fragmenting hydro-
lases. Recently we discovered the first human chitinase,
named chitotriosidase, that is specifically expressed by
phagocytes. We here report the identification, purifica-
tion, and subsequent cloning of a second mammalian
chitinase. This enzyme is characterized by an acidic
isoelectric point and therefore named acidic mamma-
lian chitinase (AMCase). In rodents and man the enzyme
is relatively abundant in the gastrointestinal tract and
is found to a lesser extent in the lung. Like chitotriosi-
dase, AMCase is synthesized as a 50-kDa protein con-
taining a 39-kDa N-terminal catalytic domain, a hinge
region, and a C-terminal chitin-binding domain. In con-
trast to chitotriosidase, the enzyme is extremely acid
stable and shows a distinct second pH optimum around
pH 2. AMCase is capable of cleaving artificial chitin-like
substrates as well as crab shell chitin and chitin as pres-
ent in the fungal cell wall. Our study has revealed the
existence of a chitinolytic enzyme in the gastrointesti-
nal tract and lung that may play a role in digestion
and/or defense.
Next to cellulose, chitin is the most abundant glycopolymer
on earth, being present as a structural component in coatings of
many species, such as the cell wall of most fungi (1), the
microfilarial sheath of parasitic nematodes (2, 3), and the exo-
skeleton of all types of arthropods (4), and in the lining of guts
of many insects (5). Chitinases (EC 3.2.1.14) are endo-b-1,4-N-
acetylglucosaminidases that can fragment chitin and have
been identified in several organisms (6). Until a few years ago
it was generally assumed that man lacks the ability to produce
a functional chitinase. Our observation of a markedly elevated
chitotriosidase activity in plasma of symptomatic Gaucher pa-
tients formed the basis for the subsequent identification of a
human phagocyte-specific chitinase, named chitotriosidase (7–
9). Tissue macrophages can synthesize large amounts of chito-
triosidase upon an appropriate stimulus, such as the massive
lysosomal lipid accumulation that occurs in macrophages of
Gaucher patients (7). Chitotriosidase is largely secreted as a
50-kDa active enzyme containing a C-terminal chitin binding
domain (10, 11). In macrophages some enzyme is proteolyti-
cally processed to a C-terminally truncated 39-kDa form with
hydrolase activity that accumulates in lysosomes of these cells
(10). The 50-kDa chitotriosidase form is also synthesized by
progenitors of neutrophilic granulocytes (9) and stored in their
specific granules (9, 12).
Chitotriosidase is remarkably homologous to chitinases from
plants, bacteria, fungi, nematodes and insects (8, 9). Analogous
to some plant chitinases, recombinant chitotriosidase has been
found to inhibit hyphal growth of chitin-containing fungi such
as Candida and Aspergillus species.1 The specific expression by
phagocytes also suggests a physiological role in defense against
chitin-containing pathogens.
A recessively inherited deficiency in chitotriosidase activity
is frequently encountered (7, 13). About 1 in 20 individuals is
completely deficient in enzymatically active chitotriosidase, be-
cause of a 24-base pair duplication in the chitotriosidase gene
(14). This duplication, which occurs panethnically, leads to
strongly reduced amounts of an abnormally spliced mRNA
only, encoding an enzymatically inactive protein that lacks an
internal stretch of 29 amino acids (14). In Caucasian popula-
tions, up to 35% of all individuals carry this abnormal chito-
triosidase allele and about 5% are homozygous for this allele
(14). The prevalence of deficiency suggests that chitotriosidase
no longer fulfills an important defense function under normal
circumstances or, alternatively, that other mechanisms may
compensate the lack of functional chitotriosidase.
To test whether compensatory mechanisms exist, we have
searched for other chitinases in mammals. The discovery of a
second mammalian chitinolytic enzyme is described here. The
properties of this acidic mammalian chitinase (AMCase)2 are
reported, and the possible implications of its existence are
discussed.
EXPERIMENTAL PROCEDURES
Enzyme Assays—Chitinase enzyme activity was determined with the
fluorogenic substrates 4-methylumbelliferyl b-D-N,N9-diacetylchito-
biose (4MU-chitobiose; Sigma) and 4-methylumbelliferyl b-D-N,N9,N0-
triacetylchitotriose (Sigma). Assay mixtures contained 0.027 mM sub-
strate and 1 mg/ml of bovine serum albumin in McIlvaine buffer (100
mM citric acid, 200 mM sodium phosphate) at the indicated pH. The
standard enzyme activity assay for human chitotriosidase with
4-methylumbelliferyl b-D-N,N9,N0-triacetylchitotriose substrate was
performed at pH 5.2, as previously described (7). The standard AMCase
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enzyme activity assays with 4MU-chitobiose substrate were performed
at pH 4.5.
Crab shell chitin (Poly- (1–4)-b-D-N-acetylglucosamine, Sigma) was
used as a natural substrate to determine chitinase activity as described
(10). The chitin fragments were analyzed by fluorophore-assisted car-
bohydrate electrophoresis as described by Jackson (15).
Degradation of Fungal Cell Wall Chitin—Measurements of chitin
formation during regeneration of fungal spheroplasts was performed as
described by Hector and Braun (16). Briefly, spheroplasts were pre-
pared from the Candida albicans strain CAi-4 (ura3), grown overnight
in YPD medium (1% yeast extract, 2% peptone, 2% glucose) at 28 °C.
Cells were concentrated by centrifugation and incubated with 2.5
mg/ml zymolyase (100T, ICN Immuno Biologicals, Costa Mesa, CA) in
buffer containing 50 mM sodium phosphate, pH 7.5, 1.2 M sorbitol, and
27 mM b-mercaptoethanol for 60 min at 37 °C. After extensive washing,
spheroplasts were allowed to regenerate in 96-well microtiter plates in
regeneration buffer (0.25% (w/v) MES buffer, pH 6.7, containing 0.17%
(w/v) yeast nitrogen base (without amino acids and ammonium sulfate;
Sigma), 0.15% (w/v) ammonium sulfate, 2% (w/v) glucose, 1.2 M sorbitol,
20 mg/ml uridine) at 37 °C. Chitinase enzyme preparations were added
to a final concentration of 3 mg/ml. After a 2-h incubation, 50 ml of 300
mg/ml Calcofluor white (Sigma) in 10 mM sodium phosphate buffer, pH
7.5, containing 1.2 M sorbitol was added. After 5 min the plates were
washed with buffer only, and fluorescence was determined using a LS
50 Perkin Elmer fluorimeter (excitation, 405 nm; emission, 450 nm).
Purification of the Mouse AMCase—Detergent-free extracts of mouse
tissues were prepared by homogenization in 10 volumes of potassium
phosphate buffer, pH 6.5, using an Ultra-turrax and centrifugation for
20 min at 15,000 3 g. The mouse intestine extract was adjusted to pH
5.0 by the addition of citric acid (0.2 M); NaCl was added to a final
concentration of 2 M. A chitin column was prepared by mixing 10 g of
swollen Sepharose G25 fine (Amersham Pharmacia Biotech) with 300
mg of colloidal chitin, followed by equilibration with phosphate-buffered
saline containing 2 M NaCl. The extracts were applied onto the column
with a flow speed of 0.4 ml/min. After extensive washing, bound chiti-
nase was eluted from the column with 8 M urea, which was subse-
quently removed by dialysis. Protein concentrations were determined
according to the method of Lowry et al. (17) using bovine serum albumin
as a standard. Fractions containing chitinase activity were subjected to
SDS-PAGE and Western blotting as described (8). N-terminal protein
sequencing was performed as described using a Procise 494 sequencer
(Applied Biosystems Perkin Elmer) (8). Colloidal chitin was prepared as
described by Shimahara and Takiguchi (18).
SDS-PAGE and Glycol-Chitin Gel Electrophoresis—SDS-PAGE was
performed with a Amersham Pharmacia Biotech phast gel system,
according to the instructions of the manufacturer, using 12.5% poly-
acrylamide gels, followed by silver staining. Glycol-chitin electrophore-
sis was conducted as described by Escott and Adams (19), except for an
extension of the renaturation time to 8 h. Glycol-chitin was prepared
from glycol chitosan (Sigma) as described by Trudel and Asselin (20).
Isoelectric Focusing—The native isoelectric point of chitinases was
determined by flat bed isoelectric focusing in granulated Ultrodex gels
(Amersham Pharmacia Biotech) as described (8).
Northern Blot and RNA Master Blot Analysis—Total RNA was iso-
lated using RNAzol B (Biosolve, Barneveld, The Netherlands) according
to the instructions of the manufacturer. Northern blots, using 15 mg of
total RNA, were performed as described (9). Human and mouse RNA
Master Blots (CLONTECH, Palo Alto, CA) were used to examine the
tissue distribution of transcripts according to the instructions of the
manufacturer. The following probes were used: the full-length mouse
acidic chitinase cDNA, the human EST clone oq35c04.s1 (GenBankTM
accession number AA976830) and glyceraldehyde-3-phosphate dehy-
drogenase as control. Radiolabeling and hybridization was conducted as
described previously (9). Quantification of radioactivity was performed
using a PhosphorImager (Molecular Dynamics, Sunnyvale, CA).
cDNA Cloning of the Mouse AMCase—Reverse transcription polym-
erase chain reaction (PCR) fragments were generated from mouse lung
total RNA using degenerate oligonucleotides, as described (9). Obtained
fragments were cloned in pGEM-T (Promega, Madison, WI), sequenced,
and compared with the amino acid sequence established by N-terminal
protein sequencing. A comparison with the GenBankTM mouse EST
(expressed sequence tag) data base using the Basic local alignment
search tool (BLAST) at the National Center for Biotechnology Informa-
tion showed that several EST clones matched the mouse chitinase
cDNA sequence, for example, ms33 h09.y1 (GenBankTM accession num-
ber AI892792). This clone was obtained and sequenced. Antisense prim-
ers were generated complementary to the most 39 region of the EST
clone (A tail primer, 59-TTTTGGCTACCAATTTTATTGC-39) and two
internal antisense primers (MAS1, 59-CAGCTACAGCAGCAGTAAC-
CATC-39 and MAS2, 59-TTCAGGGATCTCATAGCCAGC-39). The
MAS1 and MAS2 primers were used to clone the most 59 end of the
mouse acidic chitinase cDNA using 59 rapid amplification of cDNA ends
and the Marathon-Ready mouse Lung cDNA kit (CLONTECH) accord-
ing to the instructions of the manufacturer. To obtain the complete
coding sequence a 59 sense primer was generated (MS1, 59-CGATGGC-
CAAGCTACTTCTCGT-39). The total cDNA sequence was subsequently
FIG. 1. Isoelectric focusing profile of chitinolytic activity in mouse lung extract. Isoelectric focusing was performed as described under
“Experimental Procedures.” Chitinolytic activity was measured using 4MU-chitotrioside substrate. The enzyme activity present in the different
isoelectric focusing fractions is expressed as a percentage of the total activity present in all fractions.
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generated using MS1 and the A tail primer. The fragments of two
independent PCRs were cloned into pGEM-T (Promega), and the nucle-
otide sequences of two independent clones from each PCR were se-
quenced from both strands by the procedure of Sanger using fluorescent
nucleotides on an Applied Biosystems 377A automated DNA sequencer
following Applied Biosystems protocols.
cDNA Cloning of the Human AMCase—Comparison of the mouse
AMCase cDNA sequence with the human EST data base (National
FIG. 2. Mouse AMCase cDNA sequence and deduced amino acid sequence. The cDNA sequence (GenBankTM accession number
AF290003) is indicated by the upper sequence, and the deduced amino acid sequence is depicted below the nucleotide sequence. The characteristic
hydrophobic signal peptide (amino acids 1–21) is underlined with a single line. The putative chitin binding domain (amino acids 426–473) is
underlined with a double line. The hinge region separating the catalytic domain from the chitin binding domain is underlined with a dashed line.
The part of the protein purified from mouse intestine that was determined by Edman sequencing is boxed.
FIG. 3. Degradation products with colloidal chitin as sub-
strate. The fluorophore-assisted carbohydrate electrophoresis tech-
nique (described under “Experimental Procedures”) was used to visu-
alize the cleavage products of recombinant human chitotriosidase and
recombinant mouse AMCase using colloidal chitin as substrate. Lane 1,
no enzyme added. Lane 2, products formed after incubation with 50-
kDa recombinant human chitotriosidase and chitin. Lane 3, products
formed with recombinant mouse AMCase and chitin. Lane 4, human
chitotriosidase incubated without substrate. Lane 5, mouse AMCase
incubated without substrate. Marker lane is indicated with M (sugar
polymers are indicated on the right-hand side).
FIG. 4. Electrophoretic behavior of chitinases. A, purified re-
combinant human chitotriosidase and mouse AMCase were separated
on a 12.5% SDS-PAGE gel in the presence or absence of a reducing
agent and visualized by silver staining as described under “Experimen-
tal Procedures”. Lane 1, recombinant mouse AMCase under reducing
conditions. Lane 2, recombinant human chitotriosidase under reducing
conditions. Lane 3, recombinant human chitotriosidase under nonre-
ducing conditions. Lane 4, recombinant mouse AMCase under nonre-
ducing conditions. M indicates the molecular mass standards (mass
(kDa) indicated at the left-hand side). B, the same purified recombinant
enzymes as described in A were separated on a 10% SDS-PAGE gel
containing glycol-chitin as described under “Experimental Procedures.”
Chitinolytic activity was visualized as clearing zones in the gel. Lane 1,
recombinant human 39-kDa chitotriosidase. Lane 2, recombinant hu-
man 50-kDa chitotriosidase. Lane 3, recombinant mouse AMCase (mass
(kDa) indicated at the right-hand side).
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Center for Biotechnology Information) revealed the presence of a hu-
man EST clone oq35c04.s1 (GenBankTM accession number AA976830)
highly homologous to the mouse acidic chitinase. Following the same
strategy, the full-length human AMCase cDNA was cloned using hu-
man stomach total RNA (CLONTECH) for the reverse transcription
PCR with the same degenerate primers. A human Marathon-Ready
Lung cDNA was used to clone the most 59 end of the cDNA by 59 rapid
amplification of cDNA ends using the following primers: HAS2 (59-
TCTGACAGCACAGAATCCACTGCC-39) and HAS3-A tail (59-TT-
GACTGCTGATTTTATTGCAG-39). The total cDNA sequence was sub-
sequently generated using HS1 (59-GCTTTCCAGTCTGGTGGTGAAT-
39) and HAS3-A tail. The fragments of two independent PCRs were
cloned in pGEM-T (Promega) and sequenced as described above.
Transient Expression in COS-1 Cells—Transient expression of the
various cDNAs in COS-1 cells was performed exactly as described
previously (9).
RESULTS
To obtain more insight into the potential occurrence of mul-
tiple mammalian chitinases, tissues of mouse and rat were
examined for chitinolyic activity using the chitin-like 4-methyl-
umbelliferyl-b-chito-oligosaccharide substrates. In extracts of
stomach and intestine, a high level of activity was detected,
whereas extracts of lung, tongue, kidney, and plasma showed
significant but lower activities. Isoelectric focusing of a mouse
lung extract revealed a major peak of chitinolytic activity with
pI of 4.5, whereas minor peaks were found with pI levels of
5.5–6.5 (Fig. 1). Extracts of other mouse and rat tissues showed
similar profiles of chitinolytic activity upon isoelectric focusing.
The observed rodent chitinase with acidic isoelectric point (pI
4.5 form) differs strikingly from human chitotriosidase which
has an apparent neutral/basic pI.
The mouse acidic chitinase activity was found to bind to
chitin particles with high affinity. Chitin affinity chromatogra-
phy was used to purify the enzyme, as described under “Exper-
imental Procedures.” The procedure resulted in a 30,000-fold
purification of an apparently homogeneous 50-kDa protein.
The specific activity of the purified enzyme was 3.9 nmol of
4-methylumbelliferyl-chitotrioside hydrolyzed per mg per hour
at pH 5.2, which is almost identical to that of human
chitotriosidase.
The N-terminal amino acid sequence of purified acidic chiti-
nase was determined (Fig. 2) and was found to be almost
identical to that of other known members of the chitinase
family. This amino acid sequence allowed the cloning of the
corresponding full-length mouse acidic chitinase cDNA, as de-
scribed under “Experimental Procedures.” The full-length
cDNA predicts the synthesis of a 50-kDa (pI 4.85) protein with
a characteristic signal peptide (Fig. 2). Expression of this cDNA
in COS-1 cells led to the secretion of an 50-kDa active chitinase
with a pI of 4.8.
The mouse acidic chitinase protein shows considerable se-
quence homology to human chitotriosidase. Comparison of the
FIG. 5. Effects of acidic pH. A, pH
activity profile of the different chitinases.
The pH optima were determined by mon-
itoring enzyme activity at the indicated
pH in McIlvaine buffer. l, purified hu-
man recombinant chitotriosidase; l , pu-
rified mouse AMCase. B, effects of acidic
preincubation. Purified recombinant hu-
man chitotriosidase and mouse AMCase
were preincubated for 30 min at the indi-
cated pH in McIlvaine buffer prior to en-
zyme activity measurement at the assay
pH (see “Experimental Procedures”). Ac-
tivity prior to incubation at the indicated
pH is defined as 100%. C, precipitation by
trichloroacetic acid. Purified recombinant
human chitotriosidase and mouse
AMCase were incubated with the indi-
cated percentages of trichloroacetic acid
(TCA). The amount of enzyme activity
Precipitated is shown as percentage of
initial amounts.
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amino acid sequence of both mature proteins revealed an iden-
tity of 52% and a similarity of 60%. Like the human chitotrio-
sidase, the mouse enzyme is predicted to contain an N-terminal
catalytic domain of about 39 kDa, a hinge region, and a C-
terminal chitin binding domain (Fig. 2). The mouse acidic chiti-
nase, like chitotriosidase, is predicted to lack N-linked oligo-
saccharides, explaining the observed absence of binding to
concanavalin A (data not shown).
Several different assays revealed that the mouse acidic chiti-
nase is able to degrade chitin and therefore has to be consid-
ered to be a true chitinase. Firstly, fluorophore-assisted carbo-
hydrate electrophoresis analysis revealed that recombinant
mouse chitinase, like chitotriosidase, releases mainly chitobio-
side fragments from chitin (Fig. 3). Secondly, like chitotriosi-
dase and some other nonmammalian chitinases, the mouse
acidic chitinase is strongly inhibited (IC50 of 0.4 mM) by the
competitive chitinase inhibitor allosamidin (21–23). Finally,
the mouse acidic chitinase and chitotriosidase were both able to
digest chitin in the cell wall of regenerating spheroplasts of C.
albicans. The chitin content of the cell wall was determined
with the Calcofluor white stain (see “Experimental Proce-
dures”). When regenerating cells were incubated for 2 h with 3
mg/ml recombinant chitotriosidase or 3 mg/ml recombinant
mouse acidic chitinase, the chitin content was reduced by 27
and 33%, respectively. Concomitant presence of allosamidin
during the incubation completely abolished the effect of both
recombinant chitinases.
The apparent molecular masses of identically produced re-
combinant human chitotriosidase and recombinant mouse
acidic chitinase are comparable when run on a SDS-PAGE gel
under reducing conditions. However, under nonreducing con-
ditions, the mouse acidic chitinase migrates significantly
slower than the human chitotriosidase (Fig. 4A). Upon gelelec-
trophoresis (under nonreducing conditions) in polyacrylamide
gels containing glycolchitin, followed by regeneration of active
enzyme and detection of the local digestion of glycolchitin using
Calcofluor staining, the mouse acidic chitinase migrates
slightly faster than human chitotriosidase (Fig. 4B).
A further striking difference between human chitotriosidase
and the mouse acidic chitinase is their behavior at acidic pH.
The mouse acidic chitinase shows a pronounced pH optimum at
pH 2.3 and a less pronounced optimum at more neutral pH (pH
4–7). Chitotriosidase, however, shows only a broad pH opti-
mum (Fig. 5A) and is completely inactivated by pre-incubation
at low pH (Fig. 5B). In the presence of 0.5% (w/v) trichloroacetic
acid 58% of chitotriosidase is precipitated, whereas under sim-
ilar circumstances the mouse acidic chitinase remains in solu-
tion. At 2.5% (w/v) trichloroacetic acid all chitotriosidase pre-
cipitates, whereas 26% of mouse acidic chitinase remains
unprecipitated (Fig. 5C).
Another major difference between human chitotriosidase
and the mouse acidic chitinase is revealed by comparison of
RNA expression patterns. Although human chitotriosidase
mRNA is mainly found in lymph node, bone marrow, and lung,
the mouse acidic chitinase mRNA is predominantly found in
stomach, submaxillary gland, and, at a lower level, in the lung
(Fig. 6). Surprisingly, no mouse acidic chitinase mRNA can be
detected in the small intestine, suggesting that the protein in
the intestine is probably derived from the upper parts of the
gastrointestinal tract, such as the stomach.
In rat tissues a comparable acidic chitinase was observed.
Our findings indicate that the acidic chitinase in rodents is
distinct from human chitotriosidase. The discrete enzyme is
therefore referred to as acidic mammalian chitinase or AMC-
FIG. 6. Tissue distribution of mouse AMCase mRNA. A, The relative expression levels of mouse AMCase in various mouse tissues as
determined by dot blot analysis using a RNA Master Blot (CLONTECH) as described under “Experimental Procedures.” The highest level of
expression is defined as 100%. B, Northern blot of RNA isolated from the indicated mouse tissues. 15 mg of total RNA was separated on an agarose
gel as described under “Experimental Procedures.” The full-length mouse AMCase cDNA was used as probe. As a control for RNA loading a
glyceraldehyde-3-phophate dehydrogenase probe was used (data not shown). The position of the 18 S ribosomal RNA band is indicated.
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ase. It was investigated whether such an acidic chitinase is also
present in man. Screening the human EST data base at the
National Center for Biotechnology Information with the mouse
acidic chitinase cDNA revealed the presence of a highly homol-
ogous human EST clone (oq35c04.s1, GenBankTM accession
number AA976830). The tissue distribution of this human
mRNA was examined using a human Masterblot (CLON-
TECH). The expression pattern of this mRNA is similar to the
expression pattern of the mouse acidic chitinase (Fig. 7), being
highly expressed in the stomach and at a lower level in the
lung. Using degenerate oligonucleotides directed against mem-
bers of the chitinase family, we were able to amplify other
regions of the human acidic chitinase, generating enough in-
formation to clone the full-length human acidic chitinase cDNA
(Fig. 8A). Screening the GenBankTM data base using the full-
length human cDNA revealed that it was almost identical to
TSA1902-L (GenBankTM accession number AB025008) and
TSA1902-S (GenBankTM accession number AB025009) from a
lung cDNA library described by Saito et al. (24). These two
sequences are most probably splice variants of the human
acidic chitinase mRNA. Only expression of full-length human
AMCase cDNA in COS-1 cells led to the production of a protein
with chitinolytic activity (data not shown). Sequence compari-
son of the human acidic chitinase and the mouse acidic chiti-
nase revealed an 82% identity and a similarity of 86% (Fig. 8B).
The demonstration by Saito et al. (24) that the gene encoding
TSA1902 is located on chromosome 1p13 indicates that mam-
mals contain indeed at least two discrete genes that encode
functional chitinases, being chitotriosidase (locus 1q32) and
AMCase (locus 1p13). Definitive proof for the existence of at
least two distinct, functional mammalian chitinase genes was
recently obtained by the partial cloning of chitotriosidase cDNA
from the rat. The cloned rat cDNA (80% of the complete cDNA)
encodes a protein that is 80% identical to the human
counterpart.
DISCUSSION
For many years the existence of chitinase has been well
documented for a large variety of organisms, including bacte-
ria, plants, insects, and fungi (for an overview see Ref. 6). More
recently, it has become clear that mammals also contain such
enzymes. Chitotriosidase was the first mammalian chitinase
that had been cloned and characterized (7–9). Besides this
human phagocyte-specific chitinase, several inactive members
of the mammalian chitinase protein family have also been
identified. These include oviduct-specific glycoprotein from sev-
eral mammalian species (reviewed in Refs. 25–27), human HC
gp39/YKL-40 (28, 29), mouse BRP39 (30), pig gp38K (31), hu-
man YKL-39 (32), and mouse YM1/ECFL/MCRP (33, 34). The
functions of these proteins, of which some have been shown to
express lectin-like properties (35), are at present unknown. It
has been speculated that they might have a role in tissue
remodelling processes (28) or chemotaxis (33, 36).
To our knowledge chitotriosidase is the only mammalian
chitinase that has been cloned and characterized in detail so
far. Our present study describes the discovery of a second acidic
mammalian chitinase named AMCase. This enzyme is also
able to degrade artificial chitin-like substrates as well as chitin
from crab shell and chitin as present in the fungal cell wall.
Sequence homology, conservation of intron-exon boundaries
and chromosomal location suggest that the genes of members of
the mammalian chitinase protein family evolved from a com-
mon ancestor by duplication. This is also suggested by their
structural similarities, in particular between AMCase and hu-
man chitotriosidase. Both are members of family 18 of glycosyl
hydrolases, showing an 8-stranded a/b (TIM) barrel catalytic
FIG. 7. Tissue distribution of human AMCase mRNA. The relative expression levels of human AMCase in various human tissues was
determined by dot blot analysis using a RNA Master Blot (CLONTECH) using the oq35c04,s1 EST clone (GenBankTM accession number AA976830)
as probe. The highest level of expression is defined as 100%. Several tissues were excluded from the figure because they did not result in detectable
signal: amygdala, caudate nucleus, cerebellum, cerebral cortex, frontal lobe, hippocampus, medulla oblongata, occipital lobe, putamen, substantia
nigra, temporal lobe, thalamus, nucleus accumbeus, spinal cord, fetal brain, fetal heart, fetal kidney, fetal liver, fetal spleen, and fetal thymus.
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core structure (37, 38). Like chitotriosidase, AMCase contains a
N-terminal catalytic core domain of 39 kDa and a C-terminal
chitin binding domain separated by a hinge region (11). An
ongoing crystallographic study on the three-dimensional struc-
tures of human chitotriosidase and AMCase (collaboration with
F. Fusetti and B. Dijkstra from the University of Groningen,
The Netherlands) should answer some intriguing questions.
For example, the molecular basis for the profound differences
in stability and catalytic capacity at low pH between the en-
zymes has to be resolved. It will also be of interest to establish
whether the difference in migration of the two enzymes upon
SDS-PAGE at nonreducing conditions is caused by differences
in disulfide bonds. All 10 cysteines residues in chitotriosidase
are conserved in mouse AMCase. The primary amino acid
sequence of mouse AMCase shows the presence of 2 additional
cysteines in the catalytic core, which are conserved in the
human AMCase. Tjoelker et al. (11) have recently shown that
all 6 cysteines in the chitin-binding domain of human chitotrio-
sidase are involved in disulfide bonds within this domain and
are essential for lectin activity.
In view of our observation that mouse and human AMCase
mRNA is highly expressed in the stomach, the noted acidic pH
optimum and profound acid stability of AMCase is not surpris-
ing. The extreme environment in these parts of the gastroin-
testinal tract requires such special features. The fact that no
AMCase mRNA was detected in the intestine suggests that the
protein present in these lower parts of the gastrointestinal
tract may originate from the stomach and submaxillary glands.
However, AMCase EST clones have been identified in the
mouse caecum, tongue, and pancreas recently, indicating that
several additional parts of the gastrointestinal tract are in-
volved in the generation of AMCase. Whether the observed
chitinase activity in the saliva of patients with periodontal
inflammation described by van Steijn et al. (39) can be ascribed
to AMCase remains to be established.
We also observed that AMCase mRNA is expressed in the
lung (although to a lesser extent than in the stomach) and that
enzyme activity is detectable there. At present the exact cellu-
lar sources of AMCase are unknown. Recently Guoping et al.
(40) identified a silica-induced bronchoalveolar lavage protein
with fibroblast growth promoting activity in the rat. This pro-
tein is identical to the AMCase we isolated from the rat.3 It has
been shown that the protein could be identified in alveolar
macrophages of silicotic rats (40), suggesting that at least in
the rat lung this enzyme could be generated by macrophages.
However, we have been unable to demonstrate any chitinolytic
activity in rat alveolar macrophages (not shown). This could
indicate that alveolar macrophages are only capable of produc-
ing AMCase under a specific stimulus. Moreover, we have also
not observed any expression of AMCase in human monocyte-
derived macrophages, even under conditions when the cells
massively produce chitotriosidase. A detailed characterization
of the promoter regions of AMCase and chitotriosidase is re-
quired to understand the selective expression of these enzymes.
In situ hybridization analysis has to reveal which cells in the
respiratory and gastrointestinal tract can express AMCase.
For several vertebrates and invertebrates the presence of
chitinase activity in the gastrointestinal tract has been re-
ported (for an overview see Refs. 6, 41, and 42). This activity
has sometimes been ascribed to the microorganisms present in
the tract. However, gut chitinases have been cloned from sev-
eral insect species and are thought to be involved in mainte-
nance of the peritrophic matrix (43–45). The peritrophic matrix
is a chitinous extracellular layer that surrounds a food bolus in
the guts of most arthropods (46), providing a physical barrier to
pathogens, facilitating digestion, and protecting against dam-
age by food particles. Our study shows that, at least in rodents
and man, a part of the chitinolytic activity found in the gut
should be ascribed to an endogenous source also.
The presence of chitinase activity in vertebrates has actually
been described earlier, but little is known about the corre-
sponding proteins (6, 42, 47). Place (48) described the purifica-
tion of a rainbow trout chitinase, which was isolated from the
cardiac portion of the stomach. Comparison of the first 26
amino acids of this fish chitinase showed that it is 54% identi-
cal to mouse AMCase. Comparison of the complete sequence
should reveal more information regarding the evolutionary
relationship between the mammalian and fish stomach
chitinases.
At present the physiological function of AMCase is unknown.
Our study has revealed a remarkable parallel between chiti-
nases and another group of endo-glucosaminidases, the ly-
sozymes. It is well known that distinct lysozyme isoforms occur
in various organisms. Lysozymes produced by phagocytes are
basic proteins that fulfill a defense function by virtue of their
ability to degrade the cell wall of Gram-negative bacteria. In
the gastrointestinal tract of some species, acidic lysozymes are
expressed that are acid stable and active at low pH. These
enzymes are thought to function as food processors (49). By
their action, the cell walls of bacteria that ferment plant ma-
terials are degraded, allowing the subsequent release and as-
similation of their contents. It is conceivable that AMCase also
plays a role in food assimilation as earlier proposed for fish
chitinases by Lindsay (50), whereas the phagocyte-specific chi-
totriosidase is primarily involved in defense. The observation
that AMCase is also expressed in the lung may point to a dual
function for the enzyme, both in defense and food processing.
In ruminant artiodactyls, leaf-eating monkeys, and the bird
hoatzin, lysozyme has been adapted by rapid convergent evo-
lution to allow survival and functioning in the acidic, proteo-
lytic environment of the stomach (51). These adaptations
changed the global properties of the enzyme by a reduction of
the isoelectric point so that the protein is neutral or acidic
rather than basic and by a reduction in the number of acid
labile bonds and side chains (51). Similar differences can be
observed between chitotriosidase and AMCase, suggesting that
the same kind of evolutionary processes played a role in chiti-
nase adaptation.
Because AMCase is a functional chitinase, it is conceivable
that the existence of AMCase in man has allowed the high
panethnic incidence of deficiency in chitotriosidase. It will be of
great interest to study also in detail the precise composition of
chitinases and their respective functions in lower vertebrates
such as fish.
Our demonstration of a novel chitinolytic member of the
mammalian chitinase family that might play an important role
in defense and/or nutrition warrants further investigation. Re-
3 R. G. Boot, E. F. C. Blommaart, E. Swart, K. Ghauharali-van der
Vlugt, N. Bijl, C. Moe, A. Place, and J. M. F. G. Aerts, unpublished
observation.
Fig. 8. Human AMCase cDNA sequence and deduced amino acid sequence. A, the human AMCase cDNA sequence (GenBankTM accession
number AF290004) is indicated by the upper sequence, and the deduced amino acid sequence is indicated below the nucleotide sequence. The
characteristic hydrophobic signal peptide (amino acids 1–21) is underlined with a single line. B, amino acid sequence comparison of mature
(without signal peptide) human (h) and mouse (m) AMCase and human chitotriosidase. Residues conserved among at least two out of the three
sequences are boxed.
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search on structural properties, regulation of expression, and
the evolutionary relationship of the different members of the
mammalian chitinase family could give insights into the phys-
iological role of these interesting proteins.
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